Answers are grounded in this paper and cite their sources.
Identifies a reversible thrombin inhibitor in peptide nucleic acid libraries, highlighting effective therapeutic development.
Dynamic combinatorial chemistry (DCC) offers a powerful yet underutilized strategy for ligand discovery, largely limited by heterogeneous kinetic constraints in exchange reactions and analytical challenges. Here we report a peptide nucleic acid (PNA)‐templated trivalent DCC platform that enables rapid, target‐guided exploration of 125 000 assemblies to identify ultrahigh‐affinity and reversible thrombin inhibitors. Short hybridization handles allow unbiased equilibration of a three‐fragment library, and size‐exclusion filtration combined with matrix‐assisted laser desorption/ionization mass spectrometry (MALDI‐MS) provides a complete selection–readout cycle in under 1 h. From this library, thrombin amplifies synergistic fragment combinations engaging the active site and both exosites, yielding a trivalent inhibitor with apparent sub‐picomolar affinity ( K D ≈ 84 fM) and near‐stoichiometric inhibition. Despite its extreme potency, inhibition remains fully reversible: addition of a single‐stranded toehold antidote rapidly disassembles the complex and restores activity in buffer and in plasma. These results establish hybridization‐guided DCC as a fast, scalable route to programmable multivalent therapeutics with on‐demand reversibility.
No takes yet. Share an insight, caveat, or question.
Dockerill et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: